Read + Share
Amedeo Smart
Independent Medical Education
Oiwa A, Hiwatashi D, Takeda T, Miyamoto T, et al. Efficacy and safety of low-dose spironolactone for chronic kidney disease in type 2 diabetes. J Clin Endocrinol Metab 2023 Mar 14:dgad144. doi: 10.1210.PMID: 36916985
Email
LinkedIn
Facebook
Twitter
Privacy Policy